Event

G J. Mulder

MD
Promedior, Inc

Hugues Santin-Janin

MD
Venn Life Sciences

Michael Kreuter

MD, PhD
Center for Interstitial and Rare Lung Diseases, Pneumology and Respiratory Care Medicine, Thoraxklin;Center for interstitial and rare lung diseases, Pneumology, Thoraxklinik, University of Heidelberg,

Danielle E. Antin-Ozerkis

MD
Yale Univ Sch of Med;Yale University School of Medicine

Luca Richeldi

MD, PhD
Catholic University of the Sacred Heart;Clinical and Experimental Sciences, University of Southampton;Università Cattolica del Sacro Cuore, Fondazione Policlinico A. Gemelli;University of Southampton

Alberto Pesci

MD
University of Milano-Bicocca

Marlies Wijsenbeek

MD, PhD
Erasmus MC, University Medical Centre;Erasmus Medical Center;Erasmus University Medical Center

Martina Vasakova

MD, PhD
Thomayer Hospital;Thomayerova Nemocnicev

Lawrence A. Ho

MD
Univ of Washington Medical Ctr;University of Washington

Ganesh Raghu

MD
Univ of Washington Medical Ctr

Anne W. Brown

MD
Inova Fairfax Hospital

R Gupta

MD
Promedior, Inc

Mark J. Hamblin

MD
University of Kansas

K Meyer

MD
University of Wisconsin

Bernt Van Den Blink

MD
Promedior, Inc

Jeffrey A. Golden

MD
UCSF;University of California;University of California San Francisco;University of California, San Francisco

Efficacy and Safety of Recombinant Human Pentraxin-2 in Patients with Idiopathic Pulmonary Fibrosis